As shown in Additional file 1: Figure S4, we found consistent and significant alterations in the expression of Survivin and Bcl-xL, key proteins of anti-apoptotic pathways and upregulated in cancer cells [12–15], in MASTL-silenced cells versus control cells. The gene discussed is BCL2L1; the disease is cancer.